Chiropractors in Ville Platte, LA Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Kevin Dwayne Miller, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1907 East Main St, Ville Platte, LA 70586 Phone: 337-363-1554 Fax: 337-363-1554 |
Dr. Craig Allen Robin, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 625 W Main St, Ville Platte, LA 70586 Phone: 337-363-5010 |
 Nicholas C. Turk, D.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1535 W Main St, Ville Platte, LA 70586 Phone: 337-948-3343 |
Nicholas Turk, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1535 W Main St, Suite 5, Ville Platte, LA 70586 Phone: 337-363-5010 |
News Archive
Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
Researchers block immune cell rush behind deadly sepsis
Researchers have found a way to block the ability of white blood cells to sprint toward the sites of infection when such speed worsens the damage done by sepsis, the often fatal, whole-body bacterial infection, according to a study published today in the journal Blood.
FDA accepts Insys NDA for Fentanyl SL Spray to treat breakthrough cancer pain
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
Even without depression, obesity raises health costs in Group Health study
Obesity and depression both dramatically increase health care costs, but they mainly act separately, according to a study published in the November 2011 Journal of General Internal Medicine by Group Health Research Institute scientists.
Novel compound along with checkpoint inhibitors may enhance immune response in melanoma patients
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.
› Verified 4 days ago
Speech-Language Pathologists
Physical Therapists
Optometrists
Chiropractors
Occupational Therapists